VIRACTA THERAPEUTICS

EBV exists in a latent form in tumor cells. In that form, it is not susceptible to the cytotoxic activity of ganciclovir... Nanatinostat induces EBV lytic activation and expression of the EBV BGLF4 protein kinase (the "Kick")... Identifying which of your patients have EBV+ tumors may provide a new personalized treatment option.

Also known as: EBV+ Lymphoma, Viracta Therapeutics, Inc.